Abstract:Objective · To provide theoretical guidance for the design of molecules with high activity by building the quantitative structure-activity relationship (QSAR) model for tropane compounds as muscarinic M3 receptor antagonists. Methods · Six compounds (J1-J6) were prepared with3α-hydroxy-tropane (J0) as the starting material by modifying the structure in C-3α position of the tropane skeleton. The antagonistic activity of new tropane compounds to muscarinic M3 receptors on tracheal rings of guinea pigs was evaluated by functional assays in vitro. The antagonistic parameters (pA2) of new tropane compounds prepared in this paper and former studies were applied to construct the QSAR model. The information about structural optimization was acquired by analyzing the effect of steric field and electrostatic field of model on activity of tropane compounds. Results · The six new tropane compounds showed obvious antagonistic activity against M3 receptors. Among them, J4 had the greatest activity (pA2=7.992). The cross-validation correlation coefficient squared (q2) and the non-cross-validated correlation coefficient squared (r2) of the QSAR model were 0.585 and 0.993, respectively.Conclusion · The antagonistic activity to muscarinic M3 receptors can be obviously improved, when the conjugating extent of π-bonds is large and O or N atoms participate in conjugation on the rings in the R-substituting group at C-3α position of the compounds.

Synthesis and Biological Activity of Tropane Derivatives

Synthesis and Bioactivities of 3Α-Sulfonyloxy and Sulfonylamido Tropane Derivatives

Synthesis and Bioactivities of 3Α-Substituted-6β-acetoxytropane Derivatives

Synthesis of Tropane Compounds and Their Antagonistic Activity and Tissue Selectivity to Trachea of Rats

Study of antagonistic activity against M3 receptor and inhibition activity to neutrophil elastase of tropane compounds

Synthesis, Activity Determination of Tropane Compounds As Muscarinic M3 Receptor Antagonists and Quantitative Relationship Between Their Molecular Structure and Activity

Synthesis and nicotinic acetylcholine receptor affinity of bivalent tropane-3-carboxylates

[Synthesis and AchE Inhibitory Activity of 2-Phenoxy-indan-1-one Derivatives].

( S )- N -Benzyl-1-phenyl-3,4-dihydroisoqunoline-2(1 H )-carboxamide Derivatives, Multi-Target Inhibitors of Monoamine Oxidase and Cholinesterase: Design, Synthesis, and Biological Activity.

The Effect of Absolute Configuration on Activity, Subtype Selectivity (M3/M2) of 3Α-Acyloxy-6β-acetoxyltropane Derivatives As Muscarinic M3 Receptor Antagonists

Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.

Studies on the synthesis of 2H-pyran-2-one compounds and their biological activities

Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors.

Studies On Synthesis And Biological Activity Of Pyridazinone Derivatives As Alpha(1)-Adrenoceptor Antagonist

Synthesis and Anticholinesterase Activity of (−)-Physostigmine Analogues with Modifications at C3a and C5

Synthesis and Biological Evaluation of Novel Jatrorrhizine Derivatives with Amino Groups Linked at the 3-Position As Inhibitors of Acetylcholinesterase

Binding of Tropane Alkaloids to Nicotinic and Muscarinic Acetylcholine Receptors.

The optimization of a novel selective antagonist for human M<sub>2</sub> muscarinic acetylcholine receptor

Design, Synthesis, and Biological Evaluation of 4,4’-Difluorobenzhydrol Carbamates as Selective M1 Antagonists

Synthesis and Biological Characterization of 1-Methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole Derivatives As Muscarinic Agonists for the Treatment of Neurological Disorders

Design, Synthesis, Biological Evaluation and Docking Study of 4-Isochromanone Hybrids Bearing N-benzyl Pyridinium Moiety As Dual Binding Site Acetylcholinesterase Inhibitors